Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 19, 2014 - Issue 2
Submit an article Journal homepage
538
Views
7
CrossRef citations to date
0
Altmetric
Reviews

An update on emerging drugs for Hodgkin lymphoma

Bastian von TresckowUniversity Hospital of Cologne, Department I of Internal Medicine, Kerpener Str. 62, 50937 Cologne, Germany+49 221 478 97657; +49 221 478 98622; [email protected]
, MD &
Volker DiehlProfessor, Emeritus, Honorary Chairman of the German Hodgkin Study Group, University of Cologne, Internal Medicine I, Kerpener Strasse 62, Cologne 50937, Germany+49 221 4780; +49 221 478 88188; [email protected]
, MD
Pages 215-224 | Published online: 21 Apr 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Massimo Martino, Moreno Festuccia, Roberta Fedele, Giuseppe Console, Michele Cimminiello, Paolo Gavarotti & Benedetto Bruno. (2016) Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents. Expert Opinion on Biological Therapy 16:3, pages 347-364.
Read now

Articles from other publishers (6)

Pan Wang, Zi Wang & Jing Liu. (2020) Role of HDACs in normal and malignant hematopoiesis. Molecular Cancer 19:1.
Crossref
Talita Máira Bueno da Silveira da Rocha, Sergio Costa Fortier, Thais Rodrigues da Cunha Fischer, Guilherme Fleury Perini, Rafael Dezen Gaiolla, Laura Fogliatto, Marcia Torresan Delamain, Andressa Fragoso da Costa, Nelson Siqueira de Castro, Wolney Gois Barretos, Cármino Antonio de Souza, Valéria Buccheri & Carlos Sérgio Chiattone. (2017) Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience. Revista Brasileira de Hematologia e Hemoterapia 39:3, pages 216-222.
Crossref
I. Glimelius & A. Diepstra. (2016) Novel treatment concepts in Hodgkin lymphoma. Journal of Internal Medicine 281:3, pages 247-260.
Crossref
Bastian von Tresckow & Craig H. Moskowitz. (2016) Treatment of relapsed and refractory Hodgkin Lymphoma. Seminars in Hematology 53:3, pages 180-185.
Crossref
Marta Celegato, Cinzia Borghese, Naike Casagrande, Maurizio Mongiat, Xaver U. Kahle, Alice Paulitti, Michele Spina, Alfonso Colombatti & Donatella Aldinucci. (2015) Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma. Blood 126:11, pages 1394-1397.
Crossref
Bastian von Tresckow, Franck Morschhauser, Vincent Ribrag, Max S. Topp, Caly Chien, Shobha Seetharam, Regina Aquino, Sonja Kotoulek, Carla J. de Boer & Andreas Engert. (2015) An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma. Clinical Cancer Research 21:8, pages 1843-1850.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.